Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California GMO Labeling Initiative Threatens Supplements

This article was originally published in The Tan Sheet

Executive Summary

A California ballot initiative to require labeling of genetically modified foods would be a “nightmare” for supplement manufacturers, says NAI CEO Mark LeDoux. CRN President Steve Mister advocates educating consumers about GMO.

You may also be interested in...



Supplement Self-Regulation Key To Preventing More Oversight – Heinrich

The supplement industry’s new ally in the Senate, Martin Heinrich, encourages industry to increase self-regulation of energy drinks to avoid opening DSHEA to amendments. He also says national GMO labeling legislation could spare industry from a patchwork of state laws.

Supplement Self-Regulation Key To Preventing More Oversight – Heinrich

The supplement industry’s new ally in the Senate, Martin Heinrich, encourages industry to increase self-regulation of energy drinks to avoid opening DSHEA to amendments. He also says national GMO labeling legislation could spare industry from a patchwork of state laws.

GMO Labeling Movement Growing Despite Prop 37 Loss

The defeat in California of a measure to require labeling of genetically modified ingredients galvanized supporters who are pushing for similar initiatives in other states. Trade groups are working to keep controversial elements, like a bounty hunter provision, out of future efforts, and avoid a patchwork of state regulations.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105755

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel